Skip to main content

Ongoing FDAEvent 99847 (1 month ago)

Freshpoint Central Florida Cranberry Chicken Salad Wedge

Cranberry Chicken Salad Wedge has an improperly declared allergen, egg, which is not listed in the Contains statement.

Moderate risk

Eating it may cause temporary or medically reversible health problems. Serious harm is unlikely.

FDA Class II recall · How risk is rated

What to do

What happened

FRESHPOINT CENTRAL FLORIDA, INC. recalled 1093 units of its Cranberry Chicken Salad Wedge 4.5 oz package because the chicken salad sandwich has an improperly declared allergen (egg). While egg is included in the ingredients list on the package label, it is not included in the allergen Contains statement. The company began the recall on September 4, 2026, and announced it on September 8, 2026. The product is packaged in Wedge plastic and clear container with a plastic film sealing the top.

Summary by Recall Canary from the FDA notice.

What to do

If a code on your package matches:

  1. Discard the product.
  2. Customers with questions about the recall can contact: Hernan Martinez at 689-710-4467 Monday through Friday from 9AM to 5PM EST.

Is yours affected?

Match the lot code and UPC listed under your product.

  1. Cranberry Chicken Salad Wedge Sandwich

    UPC
    • 766375109617
    Lot code
    • Use By Dates of
    • 9/3/2026 to
    • 9/17/2026
    Brand
    Created Fresh!
    Pack/size
    4.5oz
  2. Cranberry Chicken Salad Wedge 4.5 oz package in Wedge plastic and clear container with a plastic film sealing the top.

    Codes
    Not listed here. See the FDA notice.

Details

Company began the recall
Event ID
99847
Company
FRESHPOINT CENTRAL FLORIDA, INC.
Quantity recalled
1093 units
  1. Company began the recall

  2. Announced by the company · Listed on Recall Canary

  3. Added to FDA's Enforcement Report · Classified by FDA

  4. Summary updated

  5. In FDA's weekly enforcement report

Summary by Recall Canary, written with AI · summary updated Oct 7, 2026 · primary source: U.S. Food and Drug Administration